Do analysts rate TLIH or BGLC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ten-League International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, TLIH or BGLC?

Ten-League International has higher revenue and earnings than BioNexus Gene Lab. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ten-League International $59.24M 0.28 $4.34M N/A N/A BioNexus Gene Lab $7.43M 0.60 -$2.98M -$1.26 N/A

Do analysts prefer SOS or BGLC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SOS 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, SOS or BGLC?

BioNexus Gene Lab has lower revenue, but higher earnings than SOS. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SOS $154.29M 0.10 -$97.32M N/A N/A BioNexus Gene Lab $7.43M 0.60 -$2.98M -$1.26 N/A

Is SOS or BGLC more profitable?

SOS has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -82.38%. SOS's return on equity of 0.00% beat BioNexus Gene Lab's return on equity. Company Net Margins Return on Equity Return on Assets SOS N/A N/A N/A BioNexus Gene Lab -82.38% -32.92% -29.75%

Do analysts rate BGLC or JBDI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 JBDI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, BGLC or JBDI?

JBDI has higher revenue and earnings than BioNexus Gene Lab. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioNexus Gene Lab $7.43M 0.60 -$2.98M -$1.26 N/A JBDI $8.44M 1.47 -$2.72M N/A N/A

Do analysts prefer BGLC or CLWT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Euro Tech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, BGLC or CLWT?

Euro Tech has higher revenue and earnings than BioNexus Gene Lab. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioNexus Gene Lab $7.43M 0.60 -$2.98M -$1.26 N/A Euro Tech $13.27M 0.93 $160K N/A N/A

Do analysts prefer INEO or BGLC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INNEOVA 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, INEO or BGLC?

INNEOVA has higher revenue and earnings than BioNexus Gene Lab. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio INNEOVA $58.42M 0.17 -$400K N/A N/A BioNexus Gene Lab $7.43M 0.60 -$2.98M -$1.26 N/A

BioNexus Gene Lab (BGLC) Competitors

$1.52 -0.03 (-1.94%)

Closing price 02:59 PM Eastern

Extended Trading

$1.54 +0.01 (+0.99%)

As of 04:27 PM Eastern

Compare

BGLC vs. TLIH, SOS, JBDI, CLWT, and INEO

Should you buy BioNexus Gene Lab stock or one of its competitors? BioNexus Gene Lab's main competitors and comparable companies include Ten-League International (TLIH), SOS (SOS), JBDI (JBDI), Euro Tech (CLWT), and INNEOVA (INEO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "trading companies & distributors" industry.

How does BioNexus Gene Lab compare to Ten-League International?

Ten-League International (NASDAQ:TLIH) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ten-League International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BioNexus Gene Lab	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

18.9% of BioNexus Gene Lab shares are owned by institutional investors. 0.1% of BioNexus Gene Lab shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Ten-League International has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -82.38%. Ten-League International's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ten-League International	N/A	N/A	N/A
BioNexus Gene Lab	-82.38%	-32.92%	-29.75%

In the previous week, Ten-League International and Ten-League International both had 1 articles in the media. Ten-League International's average media sentiment score of 0.00 equaled BioNexus Gene Lab'saverage media sentiment score.

Company	Overall Sentiment
Ten-League International	Neutral
BioNexus Gene Lab	Neutral

Ten-League International has higher revenue and earnings than BioNexus Gene Lab.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ten-League International	$59.24M	0.28	$4.34M	N/A	N/A
BioNexus Gene Lab	$7.43M	0.60	-$2.98M	-$1.26	N/A

Summary

Ten-League International beats BioNexus Gene Lab on 5 of the 8 factors compared between the two stocks.

How does BioNexus Gene Lab compare to SOS?

SOS (NYSE:SOS) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap industrials companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOS	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BioNexus Gene Lab	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

BioNexus Gene Lab has lower revenue, but higher earnings than SOS.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOS	$154.29M	0.10	-$97.32M	N/A	N/A
BioNexus Gene Lab	$7.43M	0.60	-$2.98M	-$1.26	N/A

In the previous week, BioNexus Gene Lab had 1 more articles in the media than SOS. MarketBeat recorded 1 mentions for BioNexus Gene Lab and 0 mentions for SOS. SOS's average media sentiment score of 0.00 equaled BioNexus Gene Lab'saverage media sentiment score.

Company	Overall Sentiment
SOS	Neutral
BioNexus Gene Lab	Neutral

SOS has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -82.38%. SOS's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SOS	N/A	N/A	N/A
BioNexus Gene Lab	-82.38%	-32.92%	-29.75%

SOS has a beta of 2.62, meaning that its stock price is 162% more volatile than the broader market. Comparatively, BioNexus Gene Lab has a beta of 4.17, meaning that its stock price is 317% more volatile than the broader market.

1.9% of SOS shares are held by institutional investors. Comparatively, 18.9% of BioNexus Gene Lab shares are held by institutional investors. 2.7% of SOS shares are held by company insiders. Comparatively, 0.1% of BioNexus Gene Lab shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

SOS and BioNexus Gene Lab tied by winning 5 of the 10 factors compared between the two stocks.

How does BioNexus Gene Lab compare to JBDI?

BioNexus Gene Lab (NASDAQ:BGLC) and JBDI (NASDAQ:JBDI) are both small-cap industrials companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

JBDI has higher revenue and earnings than BioNexus Gene Lab.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNexus Gene Lab	$7.43M	0.60	-$2.98M	-$1.26	N/A
JBDI	$8.44M	1.47	-$2.72M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNexus Gene Lab	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
JBDI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

BioNexus Gene Lab has a beta of 4.17, meaning that its share price is 317% more volatile than the broader market. Comparatively, JBDI has a beta of -1.12, meaning that its share price is 212% less volatile than the broader market.

18.9% of BioNexus Gene Lab shares are held by institutional investors. 0.1% of BioNexus Gene Lab shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, BioNexus Gene Lab had 1 more articles in the media than JBDI. MarketBeat recorded 1 mentions for BioNexus Gene Lab and 0 mentions for JBDI. BioNexus Gene Lab's average media sentiment score of 0.00 equaled JBDI'saverage media sentiment score.

Company	Overall Sentiment
BioNexus Gene Lab	Neutral
JBDI	Neutral

JBDI has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -82.38%. JBDI's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioNexus Gene Lab	-82.38%	-32.92%	-29.75%
JBDI	N/A	N/A	N/A

Summary

JBDI beats BioNexus Gene Lab on 6 of the 10 factors compared between the two stocks.

How does BioNexus Gene Lab compare to Euro Tech?

BioNexus Gene Lab (NASDAQ:BGLC) and Euro Tech (NASDAQ:CLWT) are both small-cap industrials companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

BioNexus Gene Lab has a beta of 4.17, suggesting that its share price is 317% more volatile than the broader market. Comparatively, Euro Tech has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

Euro Tech has higher revenue and earnings than BioNexus Gene Lab.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNexus Gene Lab	$7.43M	0.60	-$2.98M	-$1.26	N/A
Euro Tech	$13.27M	0.93	$160K	N/A	N/A

18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 2.9% of Euro Tech shares are held by institutional investors. 0.1% of BioNexus Gene Lab shares are held by company insiders. Comparatively, 79.0% of Euro Tech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, BioNexus Gene Lab and BioNexus Gene Lab both had 1 articles in the media. BioNexus Gene Lab's average media sentiment score of 0.00 equaled Euro Tech'saverage media sentiment score.

Company	Overall Sentiment
BioNexus Gene Lab	Neutral
Euro Tech	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNexus Gene Lab	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Euro Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Euro Tech has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -82.38%. Euro Tech's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioNexus Gene Lab	-82.38%	-32.92%	-29.75%
Euro Tech	N/A	N/A	N/A

Summary

Euro Tech beats BioNexus Gene Lab on 7 of the 9 factors compared between the two stocks.

How does BioNexus Gene Lab compare to INNEOVA?

INNEOVA (NASDAQ:INEO) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap industrials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

INNEOVA has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market. Comparatively, BioNexus Gene Lab has a beta of 4.17, suggesting that its stock price is 317% more volatile than the broader market.

INNEOVA has higher revenue and earnings than BioNexus Gene Lab.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INNEOVA	$58.42M	0.17	-$400K	N/A	N/A
BioNexus Gene Lab	$7.43M	0.60	-$2.98M	-$1.26	N/A

In the previous week, INNEOVA had 1 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 2 mentions for INNEOVA and 1 mentions for BioNexus Gene Lab. INNEOVA's average media sentiment score of 0.00 equaled BioNexus Gene Lab'saverage media sentiment score.

Company	Overall Sentiment
INNEOVA	Neutral
BioNexus Gene Lab	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INNEOVA	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BioNexus Gene Lab	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

INNEOVA has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -82.38%. INNEOVA's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INNEOVA	N/A	N/A	N/A
BioNexus Gene Lab	-82.38%	-32.92%	-29.75%

18.9% of BioNexus Gene Lab shares are owned by institutional investors. 0.1% of BioNexus Gene Lab shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

INNEOVA beats BioNexus Gene Lab on 6 of the 10 factors compared between the two stocks.

Get BioNexus Gene Lab News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BGLC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BGLC vs. The Competition

Export

Metric	BioNexus Gene Lab	Trading Companies & Distributors Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$4.45M	$9.50B	$10.63B	$12.77B
Dividend Yield	N/A	3.38%	97.13%	10.78%
P/E Ratio	-1.21	27.90	26.46	24.19
Price / Sales	0.60	23.27	355.14	129.00
Price / Cash	N/A	47.73	24.31	36.89
Price / Book	0.43	3.79	4.85	6.52
Net Income	-$2.98M	$375.39M	$611.55M	$347.63M
7 Day Performance	-1.30%	-1.78%	-0.88%	1.60%
1 Month Performance	0.73%	1.16%	2.25%	5.27%
1 Year Performance	-73.05%	5.71%	11.33%	17.87%

BioNexus Gene Lab Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BGLC BioNexus Gene Lab	0.323 of 5 stars	$1.52 -1.9%	N/A	-72.6%	$4.45M	$7.43M	N/A	30
TLIH Ten-League International	0.1315 of 5 stars	$5.75 +0.2%	N/A	-3.5%	$16.91M	$76.18M	N/A	64
SOS SOS	0.3971 of 5 stars	$0.93 +7.7%	N/A	-46.6%	$13.99M	$154.29M	N/A	170	Gap Up
JBDI JBDI	0.2071 of 5 stars	$1.27 -7.3%	N/A	-36.7%	$13.03M	$8.44M	N/A	121	Gap Down
CLWT Euro Tech	0.6725 of 5 stars	$1.60 -3.0%	N/A	+31.2%	$12.29M	$13.27M	N/A	40

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BGLC) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BioNexus Gene Lab (BGLC) Competitors

BGLC vs. TLIH, SOS, JBDI, CLWT, and INEO

How does BioNexus Gene Lab compare to Ten-League International?

Summary

How does BioNexus Gene Lab compare to SOS?

Summary

How does BioNexus Gene Lab compare to JBDI?

Summary

How does BioNexus Gene Lab compare to Euro Tech?

Summary

How does BioNexus Gene Lab compare to INNEOVA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BGLC vs. The Competition

BioNexus Gene Lab Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BioNexus Gene Lab (BGLC) Competitors

BGLC vs. TLIH, SOS, JBDI, CLWT, and INEO

How does BioNexus Gene Lab compare to Ten-League International?

Do analysts rate TLIH or BGLC?

Do insiders and institutionals have more ownership in TLIH or BGLC?

Is TLIH or BGLC more profitable?

Does the media favor TLIH or BGLC?

Which has higher earnings & valuation, TLIH or BGLC?

Summary

How does BioNexus Gene Lab compare to SOS?

Do analysts prefer SOS or BGLC?

Which has stronger earnings and valuation, SOS or BGLC?

Does the media prefer SOS or BGLC?

Is SOS or BGLC more profitable?

Which has more risk & volatility, SOS or BGLC?

Do insiders and institutionals hold more shares of SOS or BGLC?

Summary

How does BioNexus Gene Lab compare to JBDI?

Which has preferable valuation & earnings, BGLC or JBDI?

Do analysts rate BGLC or JBDI?

Which has more volatility & risk, BGLC or JBDI?

Do institutionals & insiders hold more shares of BGLC or JBDI?

Does the media favor BGLC or JBDI?

Is BGLC or JBDI more profitable?

Summary

How does BioNexus Gene Lab compare to Euro Tech?

Which has more volatility and risk, BGLC or CLWT?

Which has stronger valuation & earnings, BGLC or CLWT?

Do insiders & institutionals hold more shares of BGLC or CLWT?

Does the media refer more to BGLC or CLWT?

Do analysts prefer BGLC or CLWT?

Is BGLC or CLWT more profitable?

Summary

How does BioNexus Gene Lab compare to INNEOVA?

Which has more volatility & risk, INEO or BGLC?

Which has higher valuation & earnings, INEO or BGLC?

Does the media refer more to INEO or BGLC?

Do analysts prefer INEO or BGLC?

Is INEO or BGLC more profitable?

Do institutionals & insiders have more ownership in INEO or BGLC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BGLC vs. The Competition

BioNexus Gene Lab Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools